
Boys in the United Kingdom will from September be given the human papilloma virus (HPV) vaccine, the government has said. …

Dr Thomas Endress, Founder, and Dr Frederic Berkermann, co-?Founder, of a new technology being developed at the Merck Innovation Center …

Pierre Fabre chose the European Society for Medical Oncology (ESMO) 21st World Congress on Gastrointestinal Cancer in Barcelona, Spain, to …

The Department of Health and Social Care (DHSC) plans to spend £3 million on emergency transport solutions for medicines in …

Pfizer and Sangamo Therapeutics have shared new Phase 1/2 data for their investigational SB-525 gene therapy in the treatment of …

A new urine test can diagnose cases of aggressive prostate cancer more quickly than invasive biopsies. The test can also …

President Donald Trump has said that the White House is working on a ‘favoured nation clause’ to ensure the United …

British multinational GlaxoSmithKline has opened two new manufacturing plants in Singapore. The UK firm has also expanded facilities at its …

The Association of the British Pharmaceutical Industry (ABPI) has announced that its Chief Executive Mike Thompson is to retire from …

The top story of this week covered Novartis’ announcement that they did not send chemicals that could be used to …

The overall number of warning letters being sent out by the FDA has dropped under President Donald Trump, according to …

NICE has announced its decision to recommend Pfizer’s Vizimpro (Dacomitinib) in the treatment of non-small-cell lung cancer (NSCLC) – a …

A strain of the virus that causes the common cold has been found to potentially target, infect and kill cancer …

The FDA has made the controversial decision to approve the nuclear export inhibitor Xpovio (selinexor) from Karyopharm Therapeutics, in combination …

Cancer deaths cost the US economy $94.4 billion in lifetime earnings in 2015, according to figures from the American Cancer …

There have been price hikes on more than 3,400 drugs in the United States in the first six months of …

Alexion has received marketing authorisation from the European Commission for its long-acting C5 complement inhibitor Ultomiris (ravulizumab) in the treatment …

The British government has called for more research into cannabis-based medicinal products (CBMPs). In a paper published on 3 July, …

ViiV Healthcare, the specialist HIV firm majority owned by GSK, is celebrating the news that the European Commission has chosen …

American scientists have been able to combine a new form of antiretroviral therapy (ART) with gene editing tool CRISPR/Cas9 to …